Results 221 to 230 of about 639,792 (251)

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou, Marc Jaskir, Julian Gal, Yombe Fonkeu, Christos Davatzikos, MacLean P. Nasrallah, Jose Garcia, Rubo Xing, Stephen J. Bagley, Arati Desai, Richard E. Phillips, Steven Tobochnik, Colin A. Ellis, James J. Gugger, Nishant Sinha, Joel M. Stein, Kathryn A. Davis   +16 more
wiley   +1 more source

Validation and Clinical Application of the Japanese Version of the Patient-Reported Experience Measures for Intermediate Care Services: A Cross-Sectional Study. [PDF]

Healthcare (Basel)
Goto Y, Miura H.
europepmc   +1 more source

Utility and Utilization of Patient-Reported Experience Measures for the Supplementary COVID-19 Protective Actions at the Ovidius Clinical Hospital in Romania. [PDF]

Healthcare (Basel)
Pana BC, Radu CP, Furtunescu FL, Mociu A, Ciufu N.   +4 more
europepmc   +1 more source

Exploring the factors impacting choice and quality of overnight private hospital stays and consumer perspectives on patient reported experience measures (PREMs) in Australia: a qualitative interview study. [PDF]

J Patient Rep Outcomes
Verlis K, McCaffery K, Copp T, Dodd R, Laidsaar-Powell R, Nickel B.   +5 more
europepmc   +1 more source

INDAGINE PREMs PATIENT-REPORTED EXPERIENCE MEASURES - Executive Report 2024

Milena Vainieri, Elisa Peruzzo, Domenico Cerasuolo, Giuseppe D’Orio, Elisa Conti   +4 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Survival Endpoints: Patient-Reported Experience Measures and Patient-Reported Outcome Measures as Quality Indicators for Outcomes

Clinical Oncology
Heterogeneity of cancer necessitates individualised cancer care as well as tailored survival endpoints-one size no longer fits all. In the past few years, apart from the standard clinical efficacy endpoints, patient reported outcomes have gathered a momentum as one among the quality indicators in the realm of practice changing oncology.
B. Chacko, N. Jose, C.T. Kainickal
exaly   +3 more sources